CT Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $37.8K | Hold |
4,500
| – | – | 0.02% | 296 |
|
|
2016
Q4 | $28.5K | Hold |
4,500
| – | – | 0.02% | 318 |
|
|
2016
Q3 | $19.8K | Hold |
4,500
| – | – | 0.01% | 354 |
|
|
2016
Q2 | $12.8K | Buy |
4,500
+1,500
| +50% | +$4.26K | 0.01% | 400 |
|
|
2016
Q1 | $8.49K | Buy |
3,000
+2,000
| +200% | +$5.66K | ﹤0.01% | 465 |
|
|
2015
Q4 | $10.3K | Hold |
1,000
| – | – | 0.01% | 449 |
|
|
2015
Q3 | $11.4K | Hold |
1,000
| – | – | 0.01% | 442 |
|
|
2015
Q2 | $14.9K | Hold |
1,000
| – | – | 0.01% | 422 |
|
|
2015
Q1 | $9.03K | Buy |
+1,000
| New | +$9.03K | 0.01% | 476 |
|
|
2014
Q1 | $9.03K | Buy |
+1,000
| New | +$9.03K | 0.01% | 476 |
|